The present data suggest that use of NPSs, synthetic cathinones in particular, confers an elevated risk of serious cardiac arrhythmia and sudden death for KCNQ1 G643S carriers. This evidence concerns the gene KCNQ1 and chronic obstructive pulmonary disease.